Instil Bio (TIL) Other Operating Expenses (2024 - 2026)
Instil Bio (TIL) posted Other Operating Expenses of $1.6 million for Q1 2026, down 83.8% on a QoQ basis from $10.0 million in Q3 2024.
Analysis
Instil Bio (TIL) Other Operating Expenses (2024 - 2026) Analysis & Trends
Instil Bio has reported Other Operating Expenses for 2 years, with the latest figure at $1.6 million in Q1 2026.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $1.6 million in Q1 2026; TTM through Jun 2026 was $1.6 million, a 83.8% decrease from a year earlier, with the FY2025 full-year figure at $10.0 million, changed 0.0% from the prior year.
- Other Operating Expenses was $1.6 million for Q1 2026 at Instil Bio, down from $10.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $10.0 million in Q3 2024, with the low at $1.6 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Instil Bio | 50.19 Mn | 50.19 Mn | - |